Imidazonline compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S347100

Reexamination Certificate

active

07064142

ABSTRACT:
Compounds represented by the general formula (I):wherein Ar1and Ar2are each aryl or heteroaryl; R1is lower cycloalkyl, —Ar3, or a group of the general formula (a), (b) or (c):and R2and R3are each hydrogen, lower cycloalkyl, lower alkenyl, or optionally substituted lower alkyl (with the proviso that when R2and R3are simultaneously hydrogen, Ar1, Ar2and R1do not simultaneously represent unsubstituted phenyl). The compounds are useful as treating agents for various NPY-related diseases, for example, circulatory diseases including hypertension, kidney diseases, cardiac diseases, vasospasm and arteriosclerosis; central nervous system diseases including hyperphagia, depression, anxiety, convulsion, epilepsy, dementia, pain, alcohol dependence, and withdrawal symptoms due to abstinence from drugs; metabolic diseases including obesity, diabetes, hormonal disorders, hypercholesterolemia, and hyperlipidemia; sexual dysfunction and reproductive function disorders; digestive diseases including enterokinetic disorders; respiratory diseases; inflammation; or glaucoma.

REFERENCES:
patent: 3707475 (1972-12-01), Lombardino
patent: 5880139 (1999-03-01), Chang
patent: 99/01128 (1999-01-01), None
patent: 99/48888 (1999-09-01), None
Chemical Abstracts, vol. 52, No. 17240f.
Database, Accession No. 27672, XP002227829 “abstract”.
S. Wey et al., “Preparation of Primary Vicinal Diamines from Amino Acid Esters and Crystal Structure of a Chiral Nickel Salen Complex”, Tetrahedron Letters, vol. 12, No. 34, pp. 1905-1908, 1993.
R. Granger et al., vol. 250, No. 2, Apr. 4, 1960, pp. 2581-2583, XP002082608.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazonline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazonline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazonline compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3652234

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.